Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aversa SML, Salvagno L, Chiarion-Sileni V et al. (1995) Treatment of HlV-asso-ciated Kaposi’s sarcoma (KS). Proc ASCO 14:291
Bakker PJ, Danner SA, Lange JM, Veenhof KH (1988) Etoposide for epidemic Kaposi’s sarcoma: a phase II study. Eur J Cancer Clin Oncol, 24:1047–1048
Bernstein L, Hamilton AS (1993) The epidemiology of AIDS-related malignancies. Current Op Oncol 5:822–830
Bufill JA, Grace WR, Astrow AB (1992) Phase-II trial of prolonged low-dose oral VP-16 in AIDS related Kaposi’s sarcoma (KS). Proc ASCO 11:47
Cockerell C J (1991) Histopathological features of Kaposi’s sarcoma in HIV infected individuals. Cancer Surveys 10:73–89
Evans LM, Itri LM, Campion M et al. (1991) Interferon-a2a in the treatment of acquired immunodeficiency syndrome-related Kaposi’s sarcoma. J Immunother 10:39–50
Fischl MA, Krown SE, O’Boyle KP et al. (1993) Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi’s sarcoma: J Acq Immune Def Syndromes 6:259–264
Foreman KE, Friborg J, Kong W-P et al. (1997) Propagation of a human herpesvirus from AIDS-associated Kaposi’s sarcoma. N Engl J Med 336:163–171
Gill P, Rarick M, Bernstein-Singer M et al. (1990) Treatment of advanced Kaposi’s sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 13: 315–319
Gill PS, Rarick MU, Mc Cutchan JA et al. (1991) Systemic treatment of AIDS-related Kaposi’s sarcoma: Results of a randomized trial. Am J Med 90:427–433
Gill PS, Wernz J, Scadden DT et al. (1995) A randomized trial of liposomal dauno-rubicin (daunoxome) versus adriamycin, bleomycin and vincristine (ABV) in 232 patients with advanced AIDS-related Kaposi’s sarcoma. Proc. ASCO 14:291
Gill PS, Tulpule A, Reynolds T et al. (1996) Paclitaxel (Taxol) in the treatment of relapsed or refractory advanced AIDS-related Kaposi’s sarcoma. Proc ASCO 15: 306
Glaspy J, Miles S, McCarthy S et al. (1986) Treatment of advanced staged Kaposi’s sarcoma with vincristine and bleomycin. Proc ASCO 5:3
Groopman JE, Gottlieb MS, Goodman J et al. (1984) Recombinant alpha-2 interferon therapy for Kaposi’s sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 100:671–676
Guermonprez G, Katlama C, Caumes E et al. (1990) Bleomycin in the treatment of AIDS-related Kaposi’s sarcoma. Sixth Intern Conf AIDS 3:213
Hernandez DE, Perez JR (1996) Treatment of advanced epidemic Kaposi’s sarcoma (EKS) with bleomycin or a combination of doxorubicin, bleomycin, vincristine. Proc ASCO 15:308
Kaplan L, Abrams D, Volberding P (1986) Treatment of Kaposi’s sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer treat Rep 70:1121–1122
Klein E, Schwartz RA, Laor Y et al. (1980) Treatment of Kaposi’s sarcoma with vinblastine. Cancer 45:427–431
Krigel RL, Slywotzky CM, Lonberg M et al. (1988) Treatment of epidemic Kaposi’s sarcoma with a combination of interferon-alpha 2b and etoposide. J Biol Resp Mod 7:359–364
Krown SE, Metroka C, Wernz JC (1989) Kaposi’s sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response and staging criteria. J Clin Oncol 7:1201–1207
Krown SE (1990) Approaches to interferon combination therapy in the treatment of AIDS. Sem Oncol 17(1, Suppl 1): 11–15
Krown SE, Gold JWM, Niedzwiecki D et al. (1990) Interferon-a with Zidovudine: Safety, tolerance, and clinical and virologic effect in patients with Kaposi sarcoma associated with the aquired immunodeficiency syndrome (AIDS). Ann Intern Med 112:812–821
Lassoued K, Clauvel J-P, Katlama C et al. (1990) Treatment of the acquired immune deficiency syndrome-related Kaposi’s sarcoma with bleomycin as a single agent. Cancer 66:1869–1872
Laubenstein LJ, Krigel RL, Odajnyk CM et al. (1984) Treatment of epidemic Kaposi’s sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2:1115–1120
Mintzer DM, Real FX, Jovino L, Krown SE (1985) Treatment of Kaposi’s sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med 102:200–202
Mitrou PS (1996) Management of Kaposi’s sarcoma. Onkologie 19:49–52
Mitsuyasu RT (1993) Clinical aspects of AIDS-related Kaposi’s sarcoma: Current Op Oncol 5:835–844
Mitsuyasu RT, Gill P, Paredes J et al. (1995) Combination chemotherapy, adria-mycin, bleomycin, vincristine (ABV) with dideoxyinosine (ddl) or dideoxycytidine (ddc) in advanced AIDS-related Kaposi’s sarcoma (ACTG 163). Proc ASCO 14:289
Rabkin CS (1994) Epidemiology of AIDS-related malignancies. Current Op Oncol 6:492–496
Rarick MU, Gill PS, Montgomery T et al. (1990) Treatment of epidemic Kaposi’s sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol 1:147–149
Real FX, Oettgen HF, Krown SE (1986) Kaposi’s sarcoma and the acquired immunodeficiency syndrome: Treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol 4:544–551
Remick SC, Reddy M, Hermann D et al. (1994) Continuous infusion bleomycin in AIDS-related Kaposi’s sarcoma. J Clin Oncol 12:1130–1136
Saville MW, Lietzau J, Pluda JM et al. (1995) Treatment of HIV-associated Kaposi’s sarcoma with paclitaxel. Lancet 346:26–28
Volberding P, Conant MA, Strieker RB, Lewis BJ (1983) Chemotherapy in advanced Kaposi’s sarcoma. Amer J Med 74:625–656
Volberding PA, Abrams DI, Conant M et al. (1985) Vinblastine therapy for Kaposi’s sarcoma in the acquired immune deficiency syndrome. Ann Intern Med 103: 335–338
Volm MD, von Roenn JM (1995) Treatment strategies for epidemic Kaposi’s sarcoma. Curr Op Oncol 7:429–436
Wernz J, Laubenstein L, Hymes K et al. (1986) Chemotherapy and assessment of response in epidemic Kaposi’s sarcoma (EKS) with bleomycin (B)/Velban (V). Proc ASCO 5:4
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mitrou, P.S. (1998). Kaposi-Sarkom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10493-4_38
Download citation
DOI: https://doi.org/10.1007/978-3-662-10493-4_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-63821-6
Online ISBN: 978-3-662-10493-4
eBook Packages: Springer Book Archive